Auna S.A. Class A (AUNAN) AI Stock Analysis

Auna S.A. Class A

(BMV:AUNAN)

Rating:―N/A

Action:N/A

Date:―

No summary available

Positive Factors

Revenue Growth and Market ExpansionBroad-based revenue growth across three countries, supported by higher volumes and more complex care, indicates expanding demand and improving service mix. This can strengthen Auna’s regional scale, support pricing power, and provide a durable base for future operating leverage.

Negative Factors

Persistent EBITDA Margin PressureThe EBITDA outlook reset shows that revenue growth is not currently translating into comparable earnings growth. Cost pressure from a Colombian payor contract and higher operating expenses may constrain margin expansion, reduce reinvestment flexibility, and delay operating leverage.

Auna S.A. Class A Business Overview & Revenue Model

Company Description

Auna S.A. operates as a healthcare services provider, overseeing a network of hospitals and clinics across Mexico, Peru, and Colombia. The company also offers prepaid medical programs in Peru, alongside dental and vision insurance plans for clients i...

Auna S.A. Class A Earnings Call Summary

Earnings Call Date:Aug 17, 2026(Q2-2026)|Next Earnings Date:Nov 16, 2026

Earnings Call SentimentNeutral

The call presented balanced results: strong top-line growth, substantially improved cash generation and clear operational momentum (notably in Mexico, Peru membership expansion and Colombia's payer diversification) were offset by material near-term margin pressures. Adjusted EBITDA declined (consolidated -9% FX-neutral) due to investments in talent, statutory cost pressures and billing reconciliations in Peru. Management reaffirmed revenue guidance (~12% FX-neutral) and expects sequential EBITDA improvement and further leverage reduction, but open prior-period reconciliations and cost pressures create near-term uncertainty.

Positive Updates

Consolidated Revenue Growth

Consolidated revenue increased 9% year-over-year (FX-neutral), driven by volume growth and a higher mix of high-complexity services across Mexico, Peru and Colombia.

Negative Updates

Consolidated Adjusted EBITDA Decline

Consolidated adjusted EBITDA decreased 9% year-over-year on an FX-neutral basis, reflecting margin pressures across markets, investments in talent and billing-related impacts in Peru.

Company Guidance

Management reaffirmed full‑year 2026 guidance for approximately 12% FX‑neutral revenue growth and expects adjusted EBITDA to grow toward the low end of its 10–14% guidance range (excluding the impact of Peru’s accepted prior‑year billing penalties); they anticipate sequential EBITDA improvement in H2 driven by Mexico’s volume recovery, contractual price increases and stabilization of risk‑sharing and new B2B contracts, and to continue reducing leverage (which was 3.6x in Q2) toward the ~3.0x medium‑term target (management has cited <3x net debt/EBITDA); strong cash generation—cash up 43% vs. year‑end 2025 and free cash flow up 181% YoY—underpins the expectation that leverage will decline and free cash flow will continue to exceed original expectations.

Auna S.A. Class A Risk Analysis

Auna S.A. Class A disclosed 57 risk factors in its most recent earnings report. Auna S.A. Class A reported the most risks in the "Finance & Corporate" category.

Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy

Latest Risks Added

0 New Risks

Auna S.A. Class A Peers Comparison

Overall Rating

Financial Indicators

MX:AUNAN against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	51Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%

* Healthcare Sector Average

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Auna S.A. Class A AI Stock Analysis